American Century Companies Inc. Has $73.52 Million Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

American Century Companies Inc. lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 38.2% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 3,873,645 shares of the medical instruments supplier's stock after acquiring an additional 1,071,604 shares during the period. American Century Companies Inc. owned 1.95% of DENTSPLY SIRONA worth $73,522,000 as of its most recent filing with the SEC.

A number of other large investors have also modified their holdings of the company. Nordea Investment Management AB grew its position in DENTSPLY SIRONA by 245.0% in the 4th quarter. Nordea Investment Management AB now owns 251,556 shares of the medical instruments supplier's stock valued at $4,754,000 after buying an additional 178,639 shares in the last quarter. JPMorgan Chase & Co. boosted its holdings in shares of DENTSPLY SIRONA by 206.3% in the third quarter. JPMorgan Chase & Co. now owns 1,847,389 shares of the medical instruments supplier's stock valued at $49,990,000 after acquiring an additional 1,244,326 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of DENTSPLY SIRONA by 27.9% in the fourth quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier's stock valued at $45,611,000 after acquiring an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. increased its stake in shares of DENTSPLY SIRONA by 1.7% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier's stock valued at $39,880,000 after acquiring an additional 35,360 shares during the period. Finally, Barclays PLC raised its holdings in DENTSPLY SIRONA by 21.8% during the third quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier's stock worth $8,301,000 after purchasing an additional 54,920 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.

Remove Ads

Insider Activity

In other news, Director Gregory T. Lucier bought 15,142 shares of the stock in a transaction dated Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, with a total value of $249,994.42. Following the purchase, the director now owns 81,971 shares of the company's stock, valued at approximately $1,353,341.21. This represents a 22.66 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available at the SEC website. 0.52% of the stock is currently owned by corporate insiders.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY traded down $0.71 during trading on Friday, reaching $14.93. 2,436,694 shares of the company traded hands, compared to its average volume of 3,093,060. DENTSPLY SIRONA Inc. has a 1-year low of $14.78 and a 1-year high of $33.22. The company has a market cap of $2.97 billion, a price-to-earnings ratio of -7.21, a P/E/G ratio of 1.80 and a beta of 0.98. The stock's 50 day moving average price is $17.62 and its two-hundred day moving average price is $20.16. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25.

DENTSPLY SIRONA Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a dividend yield of 4.29%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA's payout ratio is -14.07%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of a number of research reports. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research note on Thursday, March 13th. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a "buy" rating on the stock in a research report on Tuesday, December 3rd. Wells Fargo & Company reduced their price objective on shares of DENTSPLY SIRONA from $20.00 to $19.00 and set an "equal weight" rating for the company in a research report on Friday, February 28th. Mizuho dropped their target price on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a report on Thursday, March 13th. Finally, Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Twelve analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average price target of $23.33.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.